285 related articles for article (PubMed ID: 11889162)
1. Two de novo mutations in the AR gene cause the complete androgen insensitivity syndrome in a pair of monozygotic twins.
Mongan NP; Jääskeläinen J; Green K; Schwabe JW; Shimura N; Dattani M; Hughes IA
J Clin Endocrinol Metab; 2002 Mar; 87(3):1057-61. PubMed ID: 11889162
[TBL] [Abstract][Full Text] [Related]
2. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
Jääskeläinen J; Mongan NP; Harland S; Hughes IA
Hum Mutat; 2006 Mar; 27(3):291. PubMed ID: 16470553
[TBL] [Abstract][Full Text] [Related]
3. L712V mutation in the androgen receptor gene causes complete androgen insensitivity syndrome due to severe loss of androgen function.
Rajender S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
Steroids; 2013 Dec; 78(12-13):1288-92. PubMed ID: 24055831
[TBL] [Abstract][Full Text] [Related]
4. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
[TBL] [Abstract][Full Text] [Related]
5. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
[TBL] [Abstract][Full Text] [Related]
6. G708E mutation in the androgen receptor results in complete loss of androgen function.
Rajender S; Pooja S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
J Androl; 2011; 32(2):193-8. PubMed ID: 20671138
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.
Ahmed SF; Cheng A; Dovey L; Hawkins JR; Martin H; Rowland J; Shimura N; Tait AD; Hughes IA
J Clin Endocrinol Metab; 2000 Feb; 85(2):658-65. PubMed ID: 10690872
[TBL] [Abstract][Full Text] [Related]
8. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling.
Köhler B; Lumbroso S; Leger J; Audran F; Grau ES; Kurtz F; Pinto G; Salerno M; Semitcheva T; Czernichow P; Sultan C
J Clin Endocrinol Metab; 2005 Jan; 90(1):106-11. PubMed ID: 15522944
[TBL] [Abstract][Full Text] [Related]
9. Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique.
De Bellis A; Quigley CA; Cariello NF; el-Awady MK; Sar M; Lane MV; Wilson EM; French FS
Mol Endocrinol; 1992 Nov; 6(11):1909-20. PubMed ID: 1480178
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of androgen insensitivity syndromes: molecular and structural approaches of natural and engineered androgen receptor mutations at amino acid 743.
Poujol N; Lumbroso S; Térouanne B; Lobaccaro JM; Bourguet W; Sultan C
J Clin Endocrinol Metab; 2002 Dec; 87(12):5793-800. PubMed ID: 12466388
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
[TBL] [Abstract][Full Text] [Related]
12. Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients.
Kawate H; Wu Y; Ohnaka K; Tao RH; Nakamura K; Okabe T; Yanase T; Nawata H; Takayanagi R
J Clin Endocrinol Metab; 2005 Nov; 90(11):6162-9. PubMed ID: 16118342
[TBL] [Abstract][Full Text] [Related]
13. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions.
Deeb A; Jääskeläinen J; Dattani M; Whitaker HC; Costigan C; Hughes IA
J Clin Endocrinol Metab; 2008 Oct; 93(10):3691-6. PubMed ID: 18697867
[TBL] [Abstract][Full Text] [Related]
15. Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome.
Raicu F; Giuliani R; Gatta V; Palka C; Franchi PG; Lelli-Chiesa P; Tumini S; Stuppia L
Asian J Androl; 2008 Jul; 10(4):687-91. PubMed ID: 18097502
[TBL] [Abstract][Full Text] [Related]
16. An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.
Elhaji YA; Wu JH; Gottlieb B; Beitel LK; Alvarado C; Batist G; Trifiro MA
Mol Endocrinol; 2004 Aug; 18(8):1876-86. PubMed ID: 15118070
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
[TBL] [Abstract][Full Text] [Related]
18. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.
De Bellis A; Quigley CA; Marschke KB; el-Awady MK; Lane MV; Smith EP; Sar M; Wilson EM; French FS
J Clin Endocrinol Metab; 1994 Mar; 78(3):513-22. PubMed ID: 8126121
[TBL] [Abstract][Full Text] [Related]
19. A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance.
Lumbroso S; Lobaccaro JM; Georget V; Leger J; Poujol N; Térouanne B; Evain-Brion D; Czernichow P; Sultan C
J Clin Endocrinol Metab; 1996 May; 81(5):1984-8. PubMed ID: 8626869
[TBL] [Abstract][Full Text] [Related]
20. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
